Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Other Non-Current Assets (2019 - 2025)

Historic Other Non-Current Assets for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $1.7 million.

  • CureVac's Other Non-Current Assets fell 54.05% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 54.05%. This contributed to the annual value of $1.6 million for FY2024, which is 1165.3% down from last year.
  • Per CureVac's latest filing, its Other Non-Current Assets stood at $1.7 million for Q3 2025, which was down 54.05% from $1.7 million recorded in Q2 2025.
  • CureVac's Other Non-Current Assets' 5-year high stood at $9.0 million during Q2 2021, with a 5-year trough of $1.6 million in Q1 2025.
  • In the last 5 years, CureVac's Other Non-Current Assets had a median value of $1.8 million in 2023 and averaged $2.2 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 11045251.62% in 2021, then crashed by 8023.19% in 2022.
  • CureVac's Other Non-Current Assets (Quarter) stood at $2.0 million in 2021, then dropped by 14.16% to $1.7 million in 2022, then grew by 7.74% to $1.8 million in 2023, then fell by 11.65% to $1.6 million in 2024, then increased by 3.84% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $1.7 million for Q2 2025, and $1.6 million during Q1 2025.